Lecture 9 Flashcards

1
Q

Structure of pancreas:

A

Pancreatic cells are found in clusters called acini. Acini are made up of millions of islets of Langerhans. Each islet has 2500 cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Secretory products of pancreatic islet cell types:

A

Alpha: glucagon
Beta: insulin
Delta: somatostatin
F: pancreatic polypeptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neural innervation of pancreatic islets:

A

Cholinergic to stimulate insulin secretion.
Alpha adrenergic to inhibit.
Beta adrenergic to stimulate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

% of pancreatic islet cell types:

A

Alpha: 20%
Beta: 70%
Delta: 7%
F: 3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biosynthesis of insulin:

A

B cells make mRNA.
Ribosomes synthesize preproinsulin.
ER folds preproinsulin into proinsulin and gives it disulfide bonds.
Trans-Golgi packages proinsulin into secretory granules.
Proteases cleave proinsulin to insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glucose transporters:

A

GLUT1 - RBCs and endothelial cells
GLUT2 - renal tubular cells, hepatic cells, pancreatic beta cells
GLUT4 - adipose, skeletal muscle, cardiac tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Regulation of insulin release by beta cell:

A

Glucose enters via GLUT2. Increased glucose metabolism increases ATP concentration. ATP inhibits out K+ channels. Depolarization activates Ca2+ channel. Increased Ca2+ leads to exocytosis of insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Composition of insulin secretion:

A

5% proinsulin, equimolar C-peptide and insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors that stimulate insulin release:

A

Increased glucose, AA, fatty acids, ketoacid.
Glucagon, growth hormone, cortisol, ACh, gastric inhibitory peptide.
Obesity.
Drugs that inhibits ATP-dependent K+ channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors that inhibit insulin release:

A

Decreased glucose.
Fasting, exercise.
Somatostatin.
Alpha-adrenergic agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin response to oral vs IV glucose:

A

Greater response to oral because of GIP’s independent stimulatory effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What kind of receptor is a insulin receptor? (2)

A

Catalytic: triggers enzymatic activity on cytoplasmic side when bound.
RTK: phosphorylates tyrosine on itself and others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin receptor structure:

A

Heterotetramer with two extracellular alpha chains and two membrane-spanning beta chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where does insulin bind on insulin receptors?

A

Cysteine-rich region of alpha chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors determining number of insulin receptors on a cell:

A

Receptor synthesis
Endocytosis of receptors
Endocytosis by degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factors determining insulin’s ability to act on a target cell:

A

Number of receptors
Receptors’ insulin affinity
Receptors’ ability to transduce insulin signal

17
Q

Mechanisms of insulin signal transmission:

A
SH2 domain proteins bind and (P)ate tyrosines on insulin receptor on lipids.
Insulin receptor (P)ates and activates other proteins.
Insulin receptor (P)ates insulin-receptor substrates (IRS).
18
Q

IRS: what are they? what they do?

A

Docking proteins for SH2 domains. Use PIP3 cascade to insert GLUT4 into membrane, and enhance glycogen synthesis. Use MAPK to activate glycogen synthase.

19
Q

IRS: different kinds

A

1, 2, 3, 4.
IRS-1: skeletal muscle.
IRS-2: hepatic insulin action, supporting pancreatic beta cells.
IRS-3 and 4: redundant.

20
Q

Lipoprotein lipase is a big weirdo:

A

Breaks down lipids and also enhances reuptake of lipids.

21
Q

Insulin effect in liver: (3)

A

Promotes glycogenesis.
Promotes lipogenesis.
Promotes protein metabolism.

22
Q

Insulin effect in muscle: (4)

A

Stimulates uptake of glucose (GLUT4).
Slightly promotes glycogenesis.
Promotes glucose breakdown.
Promotes protein synthesis (skeletal).

23
Q

Insulin effect in adipose tissue: (4)

A

Stimulates uptake of glucose (GLUT4).
Stimulates glucose breakdown.
Promotes triglyceride formation.
Promotes lipoprotein lipase synthesis.

24
Q

Hypoglycemia: manifestations

A

Early: Palpitations, tachycardia, diaphoresis, anxiety, hyperventilation, shakiness, weakness, hunger, nausea.
Prolonged/severe: confusion, unusual behaviour, hallucinations, seizures, focal neurologic deficits, coma.

25
Q

Hyperglycemia: manifestations

A

Early: weakness, polyuria, polydipsia, altered vision, weight loss, mild dehydration.
Prolonged/severe: Kussmaul hyperventilation, stupor, coma, hypotension, cardiac arrhythmias.

26
Q

Glucagon’s role during hypoglycemia:

A

Stimulating glycogenolysis, gluconeogenesis, ketogenesis

27
Q

Glucagon vs insulin:

A

Glucagon usually antagonizes insulin in the liver.

28
Q

Glucagon signalling pathway:

A

AC.

29
Q

Effects on glucagon on liver:

A

Promote glycogen breakdown.
Promote gluconeogenesis.
Promote oxidation of fats.

30
Q

Microvascular diabetic complications:

A

Retinopathy, nephropathy, neuropathy

31
Q

Macrovascular diabetic complication:

A

Coronary artery disease/heart disease, stroke, peripheral arterial disease